108 related articles for article (PubMed ID: 2823858)
21. Intraepidermal accumulation of polymorphonuclear leukocytes in annular pustular psoriasis.
van de Kerkhof PC; Lammers AM
Dermatologica; 1988; 176(6):282-7. PubMed ID: 2841175
[TBL] [Abstract][Full Text] [Related]
22. An ultrastructural study of the response of normal skin to epicutaneous application of leukotriene B4.
van de Kerkhof PC; Peereboom-Stegeman JH; Boeijen J
J Dermatol; 1991 May; 18(5):271-6. PubMed ID: 1658100
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation.
Seegers BA; Andriessen MP; van Hooijdonk CA; de Bakker ES; van Vlijmen-Willems IM; Parker GL; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2000; 13(2):75-85. PubMed ID: 10754455
[TBL] [Abstract][Full Text] [Related]
24. The effect of etretinate on fibronectin in psoriatic skin.
Lauharanta J; Salo O; Kanerva L; Lassus A
Acta Derm Venereol; 1982; 62(4):358-61. PubMed ID: 6183879
[TBL] [Abstract][Full Text] [Related]
25. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
[TBL] [Abstract][Full Text] [Related]
26. Tetracycline does not affect the trauma- and leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes.
Chang A; Steegmans P; van de Kerkhof PC
Acta Derm Venereol; 1990; 70(1):46-8. PubMed ID: 1967871
[TBL] [Abstract][Full Text] [Related]
27. Effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes in unstimulated and leukotriene B4-stimulated human skin.
Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
Skin Pharmacol; 1990; 3(1):45-8. PubMed ID: 2167697
[No Abstract] [Full Text] [Related]
28. Leukotriene B4 biosynthesis in polymorphonuclear leukocytes from blood of umbilical cord, infants, children, and adults.
Kikawa Y; Shigematsu Y; Sudo M
Pediatr Res; 1986 May; 20(5):402-6. PubMed ID: 3012451
[TBL] [Abstract][Full Text] [Related]
29. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
Lauharanta J
Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
[No Abstract] [Full Text] [Related]
30. Carbon monoxide inhibits omega-oxidation of leukotriene B4 by human polymorphonuclear leukocytes: evidence that catabolism of leukotriene B4 is mediated by a cytochrome P-450 enzyme.
Shak S; Goldstein IM
Biochem Biophys Res Commun; 1984 Sep; 123(2):475-81. PubMed ID: 6091629
[TBL] [Abstract][Full Text] [Related]
31. Novel pathway for the metabolism of 6-trans-leukotriene B4 by human polymorphonuclear leukocytes.
Powell WS
Biochem Biophys Res Commun; 1986 Apr; 136(2):707-12. PubMed ID: 3010992
[TBL] [Abstract][Full Text] [Related]
32. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
[TBL] [Abstract][Full Text] [Related]
33. Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis.
Maurice PD; Bather PC; Allen BR
Br J Dermatol; 1986 Jan; 114(1):57-64. PubMed ID: 3002416
[TBL] [Abstract][Full Text] [Related]
34. Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasis.
Osada K; Seishima M; Mori S; Seishima M; Takemura M; Noma A
Br J Dermatol; 1994 Nov; 131(5):655-9. PubMed ID: 7999596
[TBL] [Abstract][Full Text] [Related]
35. Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin.
van de Kerkhof PC; Chang A; van Dooren-Greebe R; Geiger JM; Happle R
Acta Derm Venereol; 1988; 68(6):499-503. PubMed ID: 2467488
[TBL] [Abstract][Full Text] [Related]
36. The effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes (PMN) in normal skin and LTB4-stimulated human skin.
Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
Agents Actions; 1991 Jan; 32(1-2):75-6. PubMed ID: 1647650
[No Abstract] [Full Text] [Related]
37. Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients.
Larsen FG; Nielsen-Kudsk F; Jakobsen P; Schrøder H; Kragballe K
J Clin Pharmacol; 1990 Sep; 30(9):802-7. PubMed ID: 2277127
[TBL] [Abstract][Full Text] [Related]
38. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
Denis D; Riendeau D
Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
[TBL] [Abstract][Full Text] [Related]
39. [Effect of etretinate treatment on fluidity and lipid composition of the erythrocyte membrane in patients with psoriasis].
Simonetti O; Messini L
G Ital Dermatol Venereol; 1989; 124(11-12):493-7. PubMed ID: 2638642
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports).
Kokelj F; Plozzer C; Torsello P; Trevisan G
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
